 Cannabinoid Receptor Antagonists
"Cannabinoid Receptor Antagonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds that inhibit or block the activity of CANNABINOID RECEPTORS.
| Descriptor ID |
D063387
|
| MeSH Number(s) |
D27.505.519.625.085.750 D27.505.696.399.472.188.750
|
| Concept/Terms |
Cannabinoid Receptor Antagonists- Cannabinoid Receptor Antagonists
- Antagonists, Cannabinoid Receptor
- Receptor Antagonists, Cannabinoid
- Cannabinoid Receptor Blockers
- Blockers, Cannabinoid Receptor
- Receptor Blockers, Cannabinoid
- Cannabinoid Antagonists
- Antagonists, Cannabinoid
- Cannabinoid Blockers
- Blockers, Cannabinoid
|
Below are MeSH descriptors whose meaning is more general than "Cannabinoid Receptor Antagonists".
Below are MeSH descriptors whose meaning is more specific than "Cannabinoid Receptor Antagonists".
This graph shows the total number of publications written about "Cannabinoid Receptor Antagonists" by people in UAMS Profiles by year, and whether "Cannabinoid Receptor Antagonists" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2022 | 1 | 0 | 1 | | 2020 | 0 | 1 | 1 | | 2018 | 1 | 0 | 1 | | 2016 | 0 | 1 | 1 | | 2015 | 0 | 2 | 2 | | 2013 | 1 | 0 | 1 | | 2009 | 0 | 1 | 1 | | 2004 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Cannabinoid Receptor Antagonists" by people in Profiles over the past ten years.
-
Oppong-Damoah A, Gannon BM, Murnane KS. The Endocannabinoid System and Alcohol Dependence: Will Cannabinoid Receptor 2 Agonism be More Fruitful than Cannabinoid Receptor 1 Antagonism? CNS Neurol Disord Drug Targets. 2022; 21(1):3-13.
-
Pinson A, Yarbrough AL, Bush JM, Cabanlong CV, Shoeib A, Jackson BK, Fukuda S, Gogoi J, Fantegrossi WE, McCain K, Prather PL, Fujiwara R, Radominska-Pandya A. Metabolism, CB1 cannabinoid receptor binding and in vivo activity of synthetic cannabinoid 5F-AKB48: Implications for toxicity. Pharmacol Biochem Behav. 2020 08; 195:172949.
-
Tai S, Vasiljevik T, Sherwood AM, Eddington S, Wilson CD, Prisinzano TE, Fantegrossi WE. Assessment of rimonabant-like adverse effects of purported CB1R neutral antagonist / CB2R agonist aminoalkylindole derivatives in mice. Drug Alcohol Depend. 2018 11 01; 192:285-293.
-
Ford BM, Franks LN, Radominska-Pandya A, Prather PL. Tamoxifen Isomers and Metabolites Exhibit Distinct Affinity and Activity at Cannabinoid Receptors: Potential Scaffold for Drug Development. PLoS One. 2016; 11(12):e0167240.
-
Jalin AM, Rajasekaran M, Prather PL, Kwon JS, Gajulapati V, Choi Y, Kim C, Pahk K, Ju C, Kim WK. Non-Selective Cannabinoid Receptor Antagonists, Hinokiresinols Reduce Infiltration of Microglia/Macrophages into Ischemic Brain Lesions in Rat via Modulating 2-Arachidonolyglycerol-Induced Migration and Mitochondrial Activity. PLoS One. 2015; 10(10):e0141600.
-
Tai S, Nikas SP, Shukla VG, Vemuri K, Makriyannis A, J?rbe TU. Cannabinoid withdrawal in mice: inverse agonist vs neutral antagonist. Psychopharmacology (Berl). 2015 Aug; 232(15):2751-61.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|